Ocular Therapeutix, INC
At a glance
Employees100-499
In business sinceNot reported
HeadquartersBedford, MA
US patents17
SAM.gov UEIUJ9XFB84T325
CAGE code74H00
Incorporated inDE
LEI529900ABAWFXOHSIHG03
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
17 US patents granted 2022–2025, 17 of them in the five years to SEP 2025.
Pharmaceuticals 16Medical technology 1
- Ocular implant containing a tyrosine kinase inhibitorUS 12,357,565 · granted JUL 15, 2025
- Compositions and methods for treating ocular diseasesUS 12,329,853 · granted JUN 17, 2025
- Punctal plug and bioadhesivesUS 12,310,890 · granted MAY 27, 2025
- Implant injector deviceUS 12,226,341 · granted FEB 18, 2025
- Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agentUS 12,161,753 · granted DEC 10, 2024
Newest 5 shown · Granted to Ocular Therapeutix, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Ocular Therapeutix, INC | Bedford | MA | 100–499 | ACTIVE |
WARN Act notices
- WARN notice effective AUG 2, 2024 · 37 employees · Ocular Therapeutix, INC
- WARN notice effective JUN 3, 2024 · 3 employees · Ocular Therapeutix, INC
Filed with the state under the federal WARN Act · WARN Act notices feed, CC BY 4.0
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.